Compounds > azacitidine

azacitidine and curcumin

azacitidine has been researched along with curcumin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (62.50)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Darvesh, AS; Geldenhuys, WJ; Leeper, TC; Morris, DL; Sullivan, PG; Yonutas, HM1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Capalash, N; Parashar, G; Parashar, NC1
Chang, C; Huang, CK; Jiang, Q; Lai, KP; Lee, SO; Li, L; Liang, L; Lin, TH; Luo, J; Ma, Z; Niu, Y; Tian, J; Yamashita, S; Yeh, CR; Yeh, S1
Bapat, SA; Chandra, N; Singh, AK1
Amat, P; Calabuig, M; García, F; Hernández-Boluda, JC; Martín, I; Navarro, B; Remigia, MJ; Solano, C; Tormo, M; Villamón, E1
Al-Moghrabi, N; Al-Shahrani, B; Al-Showimi, M; Al-Yousef, N; Shinwari, Z1
Hosokawa, M; Iwakawa, S; Ogawara, KI; Seiki, R1

Other Studies

8 other study(ies) available for azacitidine and curcumin

ArticleYear
Identification of small molecules that bind to the mitochondrial protein mitoNEET.
    Bioorganic & medicinal chemistry letters, 2016, 11-01, Volume: 26, Issue:21

    Topics: Hypoglycemic Agents; Ligands; Mitochondrial Proteins; Protein Binding; Small Molecule Libraries; Thiazolidinediones

2016
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell line.
    Molecular and cellular biochemistry, 2012, Volume: 365, Issue:1-2

    Topics: Azacitidine; Base Sequence; Cell Line, Tumor; Cell Survival; Curcumin; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA-Cytosine Methylases; DNA, Complementary; Epigenesis, Genetic; Fanconi Anemia Complementation Group F Protein; Humans; Inhibitory Concentration 50; Promoter Regions, Genetic; Resveratrol; Sequence Analysis, DNA; Stilbenes; Transcription, Genetic

2012
New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells.
    Journal of molecular cell biology, 2013, Volume: 5, Issue:1

    Topics: Animals; Azacitidine; Curcumin; Decitabine; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Neoplastic Stem Cells; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Xenograft Model Antitumor Assays

2013
Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Nov-15, Volume: 21, Issue:22

    Topics: Animals; Azacitidine; Benzamidines; Biomarkers, Tumor; Curcumin; Cytochrome P-450 Enzyme System; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Hydroxamic Acids; Molecular Targeted Therapy; Ovarian Neoplasms; Piperazines; Proteins; Retinoid X Receptor gamma

2015
Synergistic Antioncogenic Activity of Azacitidine and Curcumin in Myeloid Leukemia Cell Lines and Patient Samples.
    Anticancer research, 2019, Volume: 39, Issue:9

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Azacitidine; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Curcumin; Drug Synergism; Female; Humans; Leukemia, Myeloid; Male; Myelodysplastic Syndromes

2019
Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.
    Oncology reports, 2020, Volume: 43, Issue:3

    Topics: Azacitidine; BRCA1 Protein; Cell Line, Tumor; Curcumin; Disease-Free Survival; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Female; gamma-Synuclein; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Mixed Function Oxygenases; Promoter Regions, Genetic; Proto-Oncogene Proteins; Triple Negative Breast Neoplasms

2020
Combination of azacytidine and curcumin is a potential alternative in decitabine-resistant colorectal cancer cells with attenuated deoxycytidine kinase.
    Biochemical and biophysical research communications, 2021, 11-12, Volume: 578

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Line, Tumor; Colorectal Neoplasms; Curcumin; Cytidine Deaminase; Decitabine; Deoxycytidine Kinase; DNA Methylation; Drug Resistance, Neoplasm; Drug Synergism; Humans

2021